Directory
>
Suneel Gupta
Suneel Gupta
Chief Development Officer | Protagonist Therapeutics
Sunnyvale, California, United States
Suneel Gupta
Summary
Suneel Gupta is a seasoned executive with over 30 years of experience in the pharmaceutical industry, currently serving as Chief Development Officer at Protagonist Therapeutics. His extensive background includes leadership roles at Impax Pharmaceuticals and Johnson & Johnson, where he successfully oversaw the development of numerous FDA-approved drugs. Suneel's expertise spans analytical chemistry, clinical pharmacology, and drug development, demonstrating a strong commitment to advancing biopharmaceuticals. He has co-authored over 300 peer-reviewed publications and has been a pivotal figure in both product discovery and regulatory processes. His educational foundation includes a PhD from the University of Manchester and postdoctoral training at UCSF, underscoring his strong academic credentials. Suneel's professional journey reflects a blend of scientific acumen and strategic leadership, making him a prominent figure in the life sciences sector.
Suneel Gupta
Work Experience
Chief Development Officer at
Protagonist Therapeutics
January 2019 - Present
Chief Scientific Officer at
Amneal Pharmaceuticals
February 2008 - January 2019
Sr. V. P. at
Johnson & Johnson
January 2001 - January 2008
Staff Sci to VP at
Alza J And J
June 1989 - February 2001
Post Doc Fellow at
University of California, San Francisco
September 1987 - August 1989
student at
THE UNIVERSITY OF MANCHESTER
January 1983 - January 1987
Associate Production Mgr at
Ciba
January 1981 - January 1984
Suneel Gupta
Education
University of California, San Francisco, Postdoc
January 1987 - January 1989
The University of Manchester, Phd
January 1983 - January 1987
Banaras Hindu University, Mpharm
January 1978 - January 1980
Birla Institute of Technology, Bpharm
January 1974 - January 1978
Frequently Asked Questions about Suneel Gupta
What is Suneel Gupta email address?
Suneel Gupta's primary email address is ******@protagonist-inc.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Suneel Gupta work for?
Suneel Gupta is a Chief Development Officer at Protagonist Therapeutics, a company specializing in Pharmaceutical preparations.
Where Suneel Gupta graduated from?
Suneel Gupta holds a degree in Pharmacokinetics, Clinical Pharmacology from University of California, San Francisco.
How can I directly contact Suneel Gupta?
To contact Suneel Gupta directly, you can use the email address ******@protagonist-inc.com. Complete contact information is available upon registration with Muraena.
Is Suneel Gupta an immigrant?
Yes, Suneel Gupta is an immigrant and currently based in United States
Who is Suneel Gupta?
Suneel Gupta is a seasoned executive with over 30 years of experience in the pharmaceutical industry, currently serving as Chief Development Officer at Protagonist Therapeutics. His extensive background includes leadership roles at Impax Pharmaceuticals and Johnson & Johnson, where he successfully oversaw the development of numerous FDA-approved drugs. Suneel's expertise spans analytical chemistry, clinical pharmacology, and drug development, demonstrating a strong commitment to advancing biopharmaceuticals. He has co-authored over 300 peer-reviewed publications and has been a pivotal figure in both product discovery and regulatory processes. His educational foundation includes a PhD from the University of Manchester and postdoctoral training at UCSF, underscoring his strong academic credentials. Suneel's professional journey reflects a blend of scientific acumen and strategic leadership, making him a prominent figure in the life sciences sector.
Suneel`s contact details
******@protagonist-inc.com
************@impaxlabs.com
******@jnj.com
Colleagues
VP, Medical Affairs
EVP Program and Portfolio Management
Executive Director, Global Regulatory Affairs
Vice President, Regulatory Affairs
EVP & Chief Technical Officer
SVP of Biometrics
Vice President of Biometrics
Adjunct Clinical Professor, Department of Medicine, Division of Oncology
Chief Financial Officer
President & CEO